STARTUPS

Home
$
STARTUPS

Startups: From Idea to Market Impact

Your Launchpad for HealthTech Innovation

HealthTech startups face unique challenges: navigating strict regulations, securing funding, building sustainable business models and finding the right mentors. Structured incubation programmes like HCI’s Bio & Tech show that mentorship, training and networking are essential for success. Global bodies such as the OECD note that incubators and accelerators provide entrepreneurs with co‑located spaces, coaching, training, networking and financing support, while the WHO emphasises that workforce training is critical for digital‑health adoption. HCI channels these insights into services that turn ideas into market‑ready products.

What We Do – End to End Startup Support

HCI guides HealthTech startups through every stage of the innovation journey:

Business Design & Strategy

Identify unmet clinical needs and shape your product market fit through ideation workshops and strategic mentoring.

Prototyping & Testing

Access software and hardware prototyping facilities, usability testing and consumer feedback to refine your solution. Research shows that co locating early stage companies stimulates creativity and idea exchange.

Scientific & Regulatory Validation

Through PRUVA AI, HCI provides ISO 13485 design and development expertise, data privacy guidance and regulatory diagnostics. ISO 13485 is the international quality management standard that helps medical device developers meet regulatory requirements, manage risk and build trust among stakeholders.

Clinical Trials & Evidence Generation

We coordinate ethical, compliant testing with accredited laboratories and expert clinicians, ensuring your product is safe and effective.

Market Entry & Fundraising

Our team conducts market studies, competitive analyses and helps you prepare investor ready pitches. We also connect startups with local and Euro Mediterranean investors and help design distribution strategies.

Certification & Compliance

Support in obtaining CE marking and conforming to MDR/ISO standards so your device or software can enter regulated markets.

Our Vision

HCI’s strength lies in its diverse network. More than 40 experts spanning clinical evaluation, quality standards (ISO 13485, MDR, IEC 62304), biostatistics, cybersecurity and AI come together to mentor startups and review products. Partnerships with leading pharmaceutical companies (Opalia Recordati, Roche, Novo Nordisk) and academic institutions (Faculty of Pharmacy of Monastir, Institut Pasteur de Tunis) ensure that innovations are grounded in real‑world challenges.

Who We Serve

Entrepreneurs & Early Stage Startups

Looking to validate concepts and build viable business models.

Scale up Companies

Seeking regulatory guidance, market intelligence and connections to investors.

Clinicians and Researchers

Interested in commercialising their innovations or partnering with startups.

Investors & Accelerators

Who need a pipeline of vetted, compliant HealthTech opportunities.

Flagship Programmes & Success Stories

Bio & Tech Program

A start up programme hosted at the Faculty of Medicine of Monastir that guides entrepreneurs from ideation to market launch. It includes training on ISO 13485 and connects founders with global experts.

Health & Tech Incubator

HCI’s primary digital first incubation programme supporting startups from concept through product development and market entry.

OncoConnect, SAHTEE, Moodicament and other co founded ventures

Real world examples of startups that have grown within HCI’s ecosystem and now address needs in oncology, occupational health, mental wellness and more.

Our Vision

HCI’s strength lies in its diverse network. More than 40 experts spanning clinical evaluation, quality standards (ISO 13485, MDR, IEC 62304), biostatistics, cybersecurity and AI come together to mentor startups and review products. Partnerships with leading pharmaceutical companies (Opalia Recordati, Roche, Novo Nordisk) and academic institutions (Faculty of Pharmacy of Monastir, Institut Pasteur de Tunis) ensure that innovations are grounded in real‑world challenges.